Biblio

Author Title [ Type

] Year

Filters: Author is Tomuleasa, Ciprian [Clear All Filters]

Journal Article

Tatar A-S, Jurj A, Tomuleasa C, Florea A, Berindan-Neagoe I, Cialla-May D, Popp J, Astilean S, Boca S. CD19-targeted, Raman tagged gold nanourchins as theranostic agents against acute lymphoblastic leukemia. Colloids Surf B Biointerfaces. 2019;184:110478.

Tigu ABogdan, Constantinescu CSorin, Teodorescu P, Kegyes D, Munteanu R, Feder R, Peters M, Pralea I, Iuga C, Cenariu D, et al. Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia. J Cell Mol Med. 2023.

Cenariu D, Rus I, Bergthorsson JThor, Grewal R, Cenariu M, Greiff V, Tigu A-B, Dima D, Selicean C, Petrushev B, et al. Flow Cytometry of CD5-Positive Hairy Cell Leukemia. Mol Diagn Ther. 2023.

Tanase A, Tomuleasa C, Marculescu A, Bardas A, Colita A, Orban C, Ciurea SOctavian. Haploidentical Donors: Can Faster Transplantation Be Life-Saving for Patients with Advanced Disease?. Acta Haematol. 2016;135(4):211-216.

Mester A, Irimie AIulia, Tanase A, Tranca S, Campian RSeptimiu, Tomuleasa C, Dima D, Piciu A, Lucaciu O. Periodontal disease might be a risk factor for graft versus host disease. A systematic review. Crit Rev Oncol Hematol. 2020;147:102878.

Constantinescu C, Constantinescu R, Bergthorsson JThor, Greiff V, Tanase A, Colita A, Gulei D, Tomuleasa C. Pitfalls in patenting academic CAR-T cells therapy. Expert Opin Ther Pat. 2023.

Kegyes D, Gulei D, Drula R, Cenariu D, Tigu B, Dima D, Tanase A, Badelita S, Buzoianu A-D, Ciurea S, et al. Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma. Blood Rev. 2023:101100.

Gaballa S, Ge I, Fakih REl, Brammer JE, Kongtim P, Tomuleasa C, Wang SA, Lee D, Petropoulos D, Cao K, et al. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Cancer. 2016.

Rani B, Cao Y, Malfettone A, Tomuleasa C, Fabregat I, Giannelli G. Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. World J Gastroenterol. 2014;20(15):4128-4140.

Kiladjian J-J, Marin FFerrer, Al-Ali HKathrin, Alvarez-Larran A, Beggiato E, Bieniaszewska M, Breccia M, Buxhofer-Ausch V, Cerna O, Crisan A-M, et al. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options. Ann Hematol. 2024.

Kegyes D, Jitaru C, Ghiaur G, Ciurea S, Hoelzer D, Tomuleasa C, Gale RPeter. Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia. Blood Rev. 2023:101042.

Cismaru CAndrei, Tomuleasa C, Jurj A, Chira S, Isachekcu E, Cismaru G, Gherman LMadalina, Gulei D, Munteanu R, Neagoe IBerindan. Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy?. Stem Cell Rev Rep. 2023.